
Revisit top insights from SCOPE Summit 2025, where industry leaders explored how artificial intelligence is reshaping trial risk management and how pragmatic study designs are bridging the gap between clinical research and real-world care.
Vice President, Digital Innovation, IQVIA
Revisit top insights from SCOPE Summit 2025, where industry leaders explored how artificial intelligence is reshaping trial risk management and how pragmatic study designs are bridging the gap between clinical research and real-world care.
A well-designed approach can benefit clinical trials from protocol design to site support.
Published: December 12th 2024 | Updated: